May 1, 20211 minVenture ResourcesThis is a continuously updated database of venture resources to help emerging companies grow. We thank everyone who has shared their...
May 1, 20214 minLetter from our CIOWelcome to Knockout Capital. My nascent passion for finance began in university when I saw how a few scrappy kids in my statistics class...
Apr 30, 20211 minTwo Sigma Factor LensThe Two Sigma Lens is a framework for making investment decisions based on a parsimonious set of factors to gauge actionable insights.
Jan 3, 20231 minChina Equity Strategy: Alibaba, JD.com, Yum ChinaChina's market will be largely driven by continued market reforms, prominence of policy-driven thematic opportunities, diversification...
Dec 30, 20221 minFinancial Trend Reversals due to Rising Interest RatesEnd of Cheap Money and a Long Bull Market Interest rates are skyrocketing up to 5% due to rising inflation. Borrowing costs have been...
Dec 5, 20221 minBiotech Patent Litigations Most Notable: regeneron v mylan: regeneron does not seek injunctive relief but new patents filed moderna v alnylam: rejection of...
Nov 26, 20221 minGlobal Top 25 Drugs and Parent CompaniesWith the top being Pfizer, Merck, Bristol-Myers Squib, JnJ.
Mar 26, 20221 minMarch 2022: Our Startups & State of the MarketsWe're starting out newsletter again! Here's are March Issue.
Oct 19, 20211 minOur Quantamental ApproachKnockout Capital places high emphasis on equity research, as we consume much of it via conferences and sell-side on a quotidian basis as...